On Target Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ON TARGET LABS, and what generic alternatives to ON TARGET LABS drugs are available?
ON TARGET LABS has one approved drug.
There are six US patents protecting ON TARGET LABS drugs.
There are thirty-five patent family members on ON TARGET LABS drugs in twelve countries.
Summary for On Target Labs
| International Patents: | 35 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for On Target Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| On Target Labs | CYTALUX | pafolacianine sodium | SOLUTION;INTRAVENOUS | 214907-001 | Nov 29, 2021 | RX | Yes | Yes | 9,341,629 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| On Target Labs | CYTALUX | pafolacianine sodium | SOLUTION;INTRAVENOUS | 214907-001 | Nov 29, 2021 | RX | Yes | Yes | 9,061,057 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| On Target Labs | CYTALUX | pafolacianine sodium | SOLUTION;INTRAVENOUS | 214907-001 | Nov 29, 2021 | RX | Yes | Yes | 10,881,747 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for On Target Labs Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Eurasian Patent Organization | 029738 | ⤷ Subscribe |
| Israel | 240673 | ⤷ Subscribe |
| China | 105120903 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
